Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion

March 27, 2017

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-bristol-myers-squibb.jpg" NAME"Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion" ALT"Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion"March 28, 2017By <A HREF"http://www.biospace.com/news_subject_all_results.aspx?CatagoryId…
Source: BioSpace

Posted in BioPharma